Lab
Quest Diagnostics Clinical Laboratories INC
Quest Diagnostics Clinical Laboratories INC was paid $8K by Medicaid between Jan 2018 and Oct 2023, across 63 billing codes. Its largest line is 80061, Lipid panel — 13% of everything it billed.
33Billing provider infoQUEST DIAGNOSTICS CLINICAL LABORATORIES INC
NASHVILLE, TN 37228
NASHVILLE, TN 37228
33aNPI1407892243assigned 06/21/2006
33bProvider typeClinical Medical Laboratory
28Total paid$8K
24GClaims92,907
24DCodes billed63
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Tennessee
Rank by total paid#55 of 70
Median peer was paid$141K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,272 | $275.13 | |
| 2019 | 535 | $119.84 | |
| 2020 | 2,674 | $1K | |
| 2021 | 28,570 | $6K | |
| 2022 | 28,225 | $118.09 | |
| 2023 | 30,631 | $132.41 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80061 | Lipid panel | 13% | 11,016 | 8,187 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | 13% | 8,976 | 6,557 | $1K |
| 80053 | Comprehensive metabolic panel | 12% | 16,036 | 12,051 | $956.80 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 12% | 3,091 | 2,103 | $941.18 |
| 83036 | Hemoglobin; glycosylated (A1C) | 8.7% | 7,236 | 5,452 | $703.41 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.1% | 12,490 | 9,374 | $573.56 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 6.6% | 904 | 702 | $533.60 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.8% | 889 | 666 | $386.91 |
| 82607 | 4.1% | 1,961 | 1,313 | $328.17 | |
| 84153 | 2.5% | 712 | 476 | $201.49 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.6% | 1,751 | 1,341 | $132.83 |
| 82746 | 1.5% | 876 | 556 | $121.74 |
51 more codes
| 83970 | 1.3% | 942 | $105.28 | |
| 87088 | 1.2% | 1,404 | $98.29 | |
| 84439 | 1.0% | 1,908 | $82.60 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 556 | $77.26 |
| 82043 | <1% | 2,443 | $64.00 | |
| 85027 | <1% | 1,848 | $58.82 | |
| 82728 | <1% | 996 | $58.15 | |
| 82570 | <1% | 2,378 | $48.99 | |
| 80074 | <1% | 37 | $44.06 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 295 | $42.60 |
| 83550 | <1% | 999 | $39.36 | |
| 86038 | <1% | 638 | $38.96 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 945 | $38.95 |
| 83540 | <1% | 1,168 | $38.75 | |
| 87186 | <1% | 792 | $36.46 | |
| 86803 | <1% | 860 | $35.49 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 451 | $29.64 |
| 87077 | <1% | 771 | $29.13 | |
| 81001 | <1% | 1,255 | $23.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 306 | $14.30 |
| 86140 | <1% | 664 | $12.88 | |
| 83735 | <1% | 734 | $12.42 | |
| 87522 | Neg quan hep c or qual rna | <1% | 24 | $10.44 |
| 86592 | <1% | 578 | $10.04 | |
| 85652 | <1% | 692 | $7.92 | |
| 84550 | <1% | 587 | $5.88 | |
| 84436 | <1% | 216 | $3.23 | |
| 86376 | <1% | 45 | $3.20 | |
| 86431 | <1% | 243 | $3.04 | |
| 86039 | <1% | 59 | $2.70 | |
| 84479 | <1% | 123 | $2.21 | |
| 82248 | <1% | 75 | $1.95 | |
| 82550 | <1% | 91 | $0.90 | |
| 84156 | 0% | 45 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 193 | $0.00 |
| 82652 | 0% | 52 | $0.00 | |
| 86200 | 0% | 15 | $0.00 | |
| 84100 | 0% | 28 | $0.00 | |
| 85610 | 0% | 39 | $0.00 | |
| 84481 | 0% | 178 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 68 | $0.00 |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 0% | 58 | $0.00 |
| 83880 | 0% | 684 | $0.00 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 0% | 199 | $0.00 |
| 83690 | 0% | 13 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 90 | $0.00 |
| 87340 | 0% | 58 | $0.00 | |
| 84480 | 0% | 25 | $0.00 | |
| 86704 | 0% | 38 | $0.00 | |
| 87070 | 0% | 46 | $0.00 | |
| 86706 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOWLES, CHARLES (VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.